EUVIMEDEUVIMED entdecken
Crossref

Noncarbohydrate Inhibitors of Sialic Acid-Binding Immunomodulatory-Type Lectin-7 (Siglec-7) Discovered from Genetically Encoded Bicyclic Peptide Libraries

Danial Yazdan iD, A Michael Downey, Ana Gimeno iD, Caishun Li, Edward N Schmidt, Jeffrey Y K Wong iD, Caleb Loo, Jaesoo Jung, Ryan Qiu, Ewa Lis, Lily Lindmeier, June Ereño-Orbea iD und 3 weitere

Journal of the American Chemical Society · 11.11.2026 · 148 (44) · 48042-48053

DOI: 10.1021/jacs.6c14068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 08.09.2026. Verfasst von Danial Yazdan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Alberta, Edmonton, AlbertaT6G 2G2, Canada. Hauptthemen laut MEDLINE: Lectins, Peptide Library, Antigens, Differentiation, Myelomonocytic, Peptides, Cyclic. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Canada Foundation for Innovation, Canadian Institutes of Health Research (CIHR), NSERC Accelerator Supplement.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycan-binding proteins (GBPs) are among the most difficult drug targets, limiting clinical progress against therapeutically important GBPs. We employed bicyclic genetically encoded libraries (BiGELs), produced by the chemical modification of phage-displayed peptide libraries with twofold symmetric linchpins, to discover inhibitors of therapeutically relevant Siglec-7:GD3 interactions. Next-generation sequencing (NGS) analysis of BiGEL panning against Siglec-7 yielded 815 candidates, of which 23 hits yielded KD = 1–100 μM, as determined by surface plasmon resonance (SPR). Competitive enzyme-linked immunosorbent assays (ELISA) identified leads that disrupted the Siglec-7:GD3 interaction with IC50 = 3-300 μM. Machine learning models trained on NGS datasets identified additional inhibitors with equivalent potencies. Alanine scans of 8c (SWCRPATVNC, IC50 = 3.8 μM) and 12c (SFCHYPTHVC, IC50 = 11 μM) identified residues crucial for activity. Ring reshaping studies of 8c highlighted the critical role of bicyclic topology, yielding analog 46e (SAAAAAWCRPATVNC, IC50 = 9.5 μM), which was further evolved into 67e (STVTQHWCRPATVNC). The multivalent display of lead bicycles alongside ∼100 glycans in a Liquid Glycan Array (LiGA) enabled the comparison of binding to Siglec-7-expressing cells. LiGA assays confirmed the binding of the bicycles to Siglec-7 but revealed considerable nonspecific interactions with receptor-negative cells. Saturation transfer difference nuclear magnetic resonance (STD-NMR) spectroscopy revealed that 46e binds to Siglec-7 at a site distinct from the V-Ig domain, suggesting inhibition through an allosteric site. Together, these results demonstrate that BiGEL enables the discovery of bicyclic peptides for undruggable Siglec targets, but highlights future challenges in molecular discoveries that aim to identify small, noncarbohydrate inhibitors of GBPs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LectinsPeptide LibraryAntigens, Differentiation, MyelomonocyticPeptides, CyclicHumansSialic Acid Binding Immunoglobulin-like Lectins

Substanzen

LectinsPeptide LibrarySIGLEC7 protein, humanAntigens, Differentiation, MyelomonocyticPeptides, CyclicSialic Acid Binding Immunoglobulin-like Lectins

Autor:innen und Institutionen

  • Department of Chemistry, University of Alberta, Edmonton, AlbertaT6G 2G2, Canada.
  • CIC bioGUNE, Basque Research Technology Alliance, Bizkaia Technology Park, 48160Derio, Spain.
  • Ikerbasque, Basque Foundation for Science, 48009Bilbao, Spain.
  • Koliber Biosciences Inc., 12265 World Trade Drive, Suite G, San Diego, California92128, United States.
  • Department Organic & Inorganic Chemistry, UPV-EHU, 48940Leioa, Spain.
  • Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias, 28029Madrid, Spain.

ORCID-Profile: Danial Yazdan, Ana Gimeno, Jeffrey Y K Wong, June Ereño-Orbea, Jesús Jiménez-Barbero, Matthew S Macauley, Ratmir Derda

Förderung

  • Canada Foundation for Innovation
  • Canadian Institutes of Health Research (CIHR)
  • NSERC Accelerator Supplement
  • Natural Sciences and Engineering Research Council of Canada (NSERC)

Zitieren

APA

Yazdan, D., Downey, A. M., Gimeno, A., Li, C., Schmidt, E. N., Wong, J. Y. K., Loo, C., Jung, J., Qiu, R., Lis, E., Lindmeier, L., Ereño-Orbea, J., Jiménez-Barbero, J., Macauley, M. S., & Derda, R. (2026). Noncarbohydrate Inhibitors of Sialic Acid-Binding Immunomodulatory-Type Lectin-7 (Siglec-7) Discovered from Genetically Encoded Bicyclic Peptide Libraries. Journal of the American Chemical Society, 148(44), 48042-48053. https://doi.org/10.1021/jacs.6c14068

Vancouver

Yazdan D, Downey AM, Gimeno A, Li C, Schmidt EN, Wong JYK, et al. Noncarbohydrate Inhibitors of Sialic Acid-Binding Immunomodulatory-Type Lectin-7 (Siglec-7) Discovered from Genetically Encoded Bicyclic Peptide Libraries. Journal of the American Chemical Society. 2026;148(44):48042-48053. doi:10.1021/jacs.6c14068

BibTeX
@article{Yazdan2026,
  author = {Yazdan, Danial and Downey, A Michael and Gimeno, Ana and Li, Caishun and Schmidt, Edward N and Wong, Jeffrey Y K and Loo, Caleb and Jung, Jaesoo and Qiu, Ryan and Lis, Ewa and Lindmeier, Lily and Ereño-Orbea, June and Jiménez-Barbero, Jesús and Macauley, Matthew S and Derda, Ratmir},
  title = {Noncarbohydrate Inhibitors of Sialic Acid-Binding Immunomodulatory-Type Lectin-7 (Siglec-7) Discovered from Genetically Encoded Bicyclic Peptide Libraries},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  volume = {148},
  number = {44},
  pages = {48042--48053},
  doi = {10.1021/jacs.6c14068}
}
Kostenlos starten →